tiprankstipranks
Trending News
More News >
CK Life Sciences International (Holdings), Inc. (HK:0775)
:0775
Hong Kong Market

CK Life Sciences International (Holdings), Inc. (0775) Ratios

Compare
3 Followers

CK Life Sciences International (Holdings), Inc. Ratios

HK:0775's free cash flow for Q4 2024 was HK$0.31. For the 2024 fiscal year, HK:0775's free cash flow was decreased by HK$ and operating cash flow was HK$-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.28 1.42 0.77 1.53 3.60
Quick Ratio
0.78 0.85 0.45 0.92 2.10
Cash Ratio
0.24 0.32 0.17 0.43 1.05
Solvency Ratio
>-0.01 0.04 0.03 0.04 0.03
Operating Cash Flow Ratio
0.15 0.24 0.09 0.20 0.58
Short-Term Operating Cash Flow Coverage
0.28 0.45 0.12 0.35 0.00
Net Current Asset Value
HK$ -4.31BHK$ -4.07BHK$ -3.99BHK$ -4.06BHK$ -3.97B
Leverage Ratios
Debt-to-Assets Ratio
0.57 0.53 0.53 0.53 0.52
Debt-to-Equity Ratio
1.74 1.42 1.43 1.38 1.31
Debt-to-Capital Ratio
0.63 0.59 0.59 0.58 0.57
Long-Term Debt-to-Capital Ratio
0.54 0.50 0.36 0.49 0.54
Financial Leverage Ratio
3.07 2.68 2.71 2.60 2.54
Debt Service Coverage Ratio
0.19 0.39 0.12 0.28 2.79
Interest Coverage Ratio
2.32 0.69 2.08 3.44 1.93
Debt to Market Cap
1.39 0.91 0.72 0.79 0.66
Interest Debt Per Share
0.67 0.65 0.64 0.66 0.66
Net Debt to EBITDA
16.44 8.43 11.19 11.85 14.79
Profitability Margins
Gross Profit Margin
30.65%30.76%30.82%30.17%28.47%
EBIT Margin
4.45%7.35%6.97%6.20%4.98%
EBITDA Margin
6.11%11.74%8.90%8.31%7.15%
Operating Profit Margin
14.18%4.21%6.44%6.22%5.01%
Pretax Profit Margin
-1.66%1.29%3.88%4.41%2.41%
Net Profit Margin
-2.29%0.32%2.50%3.01%2.53%
Continuous Operations Profit Margin
-2.29%0.32%2.50%2.99%2.53%
Net Income Per EBT
138.34%25.15%64.41%68.34%105.13%
EBT Per EBIT
-11.68%30.64%60.32%70.89%48.06%
Return on Assets (ROA)
-1.17%0.15%1.17%1.39%1.05%
Return on Equity (ROE)
-3.60%0.41%3.17%3.61%2.65%
Return on Capital Employed (ROCE)
9.24%2.45%4.71%3.48%2.24%
Return on Invested Capital (ROIC)
11.02%0.54%2.12%2.10%2.34%
Return on Tangible Assets
-1.72%0.22%1.72%2.02%1.52%
Earnings Yield
-3.21%0.29%1.74%2.29%1.46%
Efficiency Ratios
Receivables Turnover
5.05 5.96 5.31 6.01 5.85
Payables Turnover
11.53 10.29 8.86 13.52 11.26
Inventory Turnover
3.31 3.06 2.84 3.01 2.58
Fixed Asset Turnover
2.15 1.94 2.03 1.95 1.76
Asset Turnover
0.51 0.47 0.47 0.46 0.41
Working Capital Turnover Ratio
7.16 -233.66 67.39 3.11 5.35
Cash Conversion Cycle
150.87 145.11 156.03 155.08 171.40
Days of Sales Outstanding
72.23 61.28 68.73 60.76 62.38
Days of Inventory Outstanding
110.29 119.29 128.51 121.32 141.44
Days of Payables Outstanding
31.65 35.47 41.21 26.99 32.43
Operating Cycle
182.52 180.58 197.24 182.08 203.82
Cash Flow Ratios
Operating Cash Flow Per Share
0.04 0.05 0.04 0.04 0.06
Free Cash Flow Per Share
0.02 0.02 0.02 0.02 0.02
CapEx Per Share
0.02 0.03 0.02 0.02 0.04
Free Cash Flow to Operating Cash Flow
0.44 0.43 0.40 0.49 0.28
Dividend Paid and CapEx Coverage Ratio
1.80 1.39 1.16 1.35 1.12
Capital Expenditure Coverage Ratio
1.80 1.76 1.68 1.95 1.40
Operating Cash Flow Coverage Ratio
0.06 0.09 0.06 0.07 0.09
Operating Cash Flow to Sales Ratio
0.06 0.10 0.07 0.08 0.11
Free Cash Flow Yield
3.91%3.73%1.93%2.90%1.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-31.14 345.44 57.54 43.69 68.30
Price-to-Sales (P/S) Ratio
0.71 1.12 1.44 1.32 1.73
Price-to-Book (P/B) Ratio
1.12 1.42 1.83 1.58 1.81
Price-to-Free Cash Flow (P/FCF) Ratio
25.58 26.80 51.76 34.47 56.60
Price-to-Operating Cash Flow Ratio
11.15 11.59 20.88 16.79 16.11
Price-to-Earnings Growth (PEG) Ratio
0.04 -3.98 -3.04 1.46 -2.19
Price-to-Fair Value
1.12 1.42 1.83 1.58 1.81
Enterprise Value Multiple
28.13 17.97 27.36 27.68 38.98
Enterprise Value
EV to EBITDA
28.13 17.97 27.36 27.68 38.98
EV to Sales
1.72 2.11 2.44 2.30 2.79
EV to Free Cash Flow
61.57 50.49 87.58 60.27 91.22
EV to Operating Cash Flow
26.83 21.83 35.33 29.36 25.96
Tangible Book Value Per Share
<0.01 0.06 0.06 0.09 0.10
Shareholders’ Equity Per Share
0.37 0.44 0.43 0.47 0.49
Tax and Other Ratios
Effective Tax Rate
-0.38 0.75 0.36 0.32 -0.05
Revenue Per Share
0.57 0.55 0.55 0.56 0.51
Net Income Per Share
-0.01 <0.01 0.01 0.02 0.01
Tax Burden
1.38 0.25 0.64 0.68 1.05
Interest Burden
-0.37 0.18 0.56 0.71 0.48
Research & Development to Revenue
0.05 0.03 0.03 0.03 0.03
SG&A to Revenue
0.02 0.02 0.01 0.02 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-2.79 29.81 1.78 1.78 4.46
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis